Case ReportInternational Journal of Research in Medical Sciences

Publication:
Idiopathic multicentric Castleman disease: a mysterious case of generalized lymphadenopathy

Int J Res Med Sci. 2023;11(8):3087-3091.DOI10.18203/2320-6012.ijrms20232455

Thumbnail Image
View on the journal's website(opens in a new tab)

Abstract

Castleman disease is a syndrome with significant clinico-pathological overlap between malignancy, autoimmune causes and infectious etiologies. It is a spectrum and can vary in extent from unicentric to multicentric disease with generalized lymphadenopathy, organ involvement, constitutional symptoms and cytopenias, and in severity from non-severe to severe disease with TAFRO symptoms. Idiopathic multicentric Castleman disease (iMCD) is a diagnosis of exclusion after multiple causes as per diagnostic criteria are excluded. Treatment varies between the disease severity types with anti-IL 6 antibodies for non-severe disease to cytotoxic chemotherapy agents for severe disease with TAFRO symptoms. We hereby report a case of a non-severe type of iMCD with a prolonged course and delayed arrival at the diagnosis, owing to the rarity of this condition, which stresses the need for a reduced threshold to consider MCD, early in the differential diagnosis. Interestingly there were positive auto-antibodies and elevated IgG4 levels in this patient, but applying strict criteria helps to distinguish the diagnosis.

Keywords

Affiliations

  1. Department of Medical Oncology, Apollo Cancer Centre, Chennai, Tamil Nadu, India
  2. Department of Pathology, Apollo Cancer Centre, Chennai, Tamil Nadu, India
  3. Department of Medical Oncology, Apollo Cancer Centre, Chennai, Tamil Nadu, India

Full item record